Lancet · 2016
Alzheimer's disease
Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Frisoni GB, Salloway S, Van der Flier WM.
Show affiliations
- Scheltens P — Department of Neurology & Alzheimer Center, VU University Medical Center, Amsterdam, Netherlands. Electronic address: p.scheltens@vumc.nl.
- Blennow K — Clinical Neurochemistry Lab, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Breteler MM — German Center for Neurodegenerative diseases (DZNE), and Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.
- de Strooper B — VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium; KU Leuven Center for Human Genetics, LIND en Universitaire ziekenhuizen, Leuven, Belgium; Institute of Neurology, University College London, London, UK.
- Frisoni GB — University Hospitals and University of Geneva, Geneva, Switzerland; IRCCS Fatebenefratelli, Brescia, Italy.
- Frisoni GB — University Hospitals and University of Geneva, Geneva, Switzerland; IRCCS Fatebenefratelli, Brescia, Italy.
- Salloway S — Warren Alpert Medical School, Brown University, Providence, RI, USA.
- Van der Flier WM — Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands.
9 read2 want to readRigor 3.3Novelty 3.3Impact 3.3Reprod. 2.9
Most-cited papers citing this
- Signal Transduct Target Ther · 2025 · cited by 26
- Alzheimers Dement · 2025 · cited by 3
- Proteomics · 2026 · cited by 3
- J Neurosci · 2025 · cited by 2
- Cell Biochem Funct · 2025 · cited by 2
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0